|
1
|
Goodenberger ML and Jenkins RB: Genetics
of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Agarwal S, Sane R, Oberoi R, Ohlfest JR
and Elmquist WF: Delivery of molecularly targeted therapy to
malignant glioma, a disease of the whole brain. Expert Rev Mol Med.
13:e172011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stewart LA: Chemotherapy in adult
high-grade glioma: A systematic review and meta-analysis of
individual patient data from 12 randomised trials. Lancet.
359:1011–1018. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu VF, Yang J, Lebrun DG and Li M:
Understanding the role of cytokines in Glioblastoma Multiforme
pathogenesis. Cancer Lett. 316:139–150. 2012. View Article : Google Scholar
|
|
5
|
Pulkkanen KJ and Yla-Herttuala S: Gene
therapy for malignant glioma: Current clinical status. Mol Ther.
12:585–598. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moss EG: MicroRNAs: Hidden in the genome.
Curr Biol. 12:R138–R140. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Choi E, Choi E and Hwang KC: MicroRNAs as
novel regulators of stem cell fate. World J Stem Cells. 5:172–187.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lujambio A, Calin GA, Villanueva A, Ropero
S, Sanchez-Cespedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso
MS, Faller WJ, et al: A microRNA DNA methylation signature for
human cancer metastasis. Proc Natl Acad Sci USA. 105:13556–13561.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Men D, Liang Y and Chen L: Decreased
expression of microRNA-200b is an independent unfavorable
prognostic factor for glioma patients. Cancer Epidemiol.
38:152–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Q, Tang H, Liu X, Liao Y, Li H, Zhao
Z, Yuan X and Jiang W: miR-200b as a prognostic factor targets
multiple members of RAB family in glioma. Med Oncol. 31:8592014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng B, Hu S, Jun Q, Luo D, Zhang X, Zhao
H and Li D: MicroRNA-200b targets CREB1 and suppresses cell growth
in human malignant glioma. Mol Cell Biochem. 379:51–58. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Remacle JE, Kraft H, Lerchner W, Wuytens
G, Collart C, Verschueren K, Smith JC and Huylebroeck D: New mode
of DNA binding of multi-zinc finger transcription factors: deltaEF1
family members bind with two hands to two target sites. EMBO J.
18:5073–5084. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Beuran M, Negoi I, Paun S, Ion AD, Bleotu
C, Negoi RI and Hostiuc S: The epithelial to mesenchymal transition
in pancreatic cancer: A systematic review. Pancreatology.
15:217–225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zielinska HA, Bahl A, Holly JM and Perks
CM: Epithelialto-mesenchymal transition in breast cancer: A role
for insulin-like growth factor I and insulin-like growth
factor-binding protein 3? Breast Cancer (Dove Med Press). 7:9–19.
2015.
|
|
16
|
Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX,
Shetuni B and Barsky SH: ERalpha signaling through slug regulates
E-cadherin and EMT. Oncogene. 29:1451–1462. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nam EH, Lee Y, Park YK, Lee JW and Kim S:
ZEB2 upregulates integrin alpha5 expression through cooperation
with Sp1 to induce invasion during epithelial-mesenchymal
transition of human cancer cells. Carcinogenesis. 33:563–571. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qi S, Song Y, Peng Y, Wang H, Long H, Yu
X, Li Z, Fang L, Wu A, Luo W, et al: ZEB2 mediates multiple
pathways regulating cell proliferation, migration, invasion, and
apoptosis in glioma. PLoS One. 7:e388422012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Z, Long X, Chao C, Yan C, Wu Q, Hua S,
Zhang Y, Wu A and Fang W: Knocking down CDK4 mediates the elevation
of let-7c suppressing cell growth in nasopharyngeal carcinoma. BMC
Cancer. 14:2742014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu B, Che W, Xue J, Zheng C, Tang K,
Zhang J, Wen J and Xu Y: SIRT4 prevents hypoxia-induced apoptosis
in H9c2 cardiomyoblast cells. Cell Physiol Biochem. 32:655–662.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
An L, Liu Y, Wu A and Guan Y: microRNA-124
inhibits migration and invasion by down-regulating ROCK1 in glioma.
PLoS One. 8:e694782013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gabriely G, Wurdinger T, Kesari S, Esau
CC, Burchard J, Linsley PS and Krichevsky AM: MicroRNA 21 promotes
glioma invasion by targeting matrix metalloproteinase regulators.
Mol Cell Biol. 28:5369–5380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rani SB, Rathod SS, Karthik S, Kaur N,
Muzumdar D and Shiras AS: MiR-145 functions as a tumor-suppressive
RNA by targeting Sox9 and adducin 3 in human glioma cells. Neuro
Oncol. 15:1302–1316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ning X, Shi Z, Liu X, Zhang A, Han L,
Jiang K, Kang C and Zhang Q: DNMT1 and EZH2 mediated methylation
silences the microRNA-200b/a/429 gene and promotes tumor
progression. Cancer Lett. 359:198–205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Williams LV, Veliceasa D, Vinokour E and
Volpert OV: miR-200b inhibits prostate cancer EMT, growth and
metastasis. PLoS One. 8:e839912013. View Article : Google Scholar
|
|
26
|
Yu J, Lu Y, Cui D, Li E, Zhu Y, Zhao Y,
Zhao F and Xia S: miR-200b suppresses cell proliferation, migration
and enhances chemosensitivity in prostate cancer by regulating
Bmi-1. Oncol Rep. 31:910–918. 2014.
|
|
27
|
Yoneyama K, Ishibashi O, Kawase R, Kurose
K and Takeshita T: miR-200a, miR-200b and miR-429 are onco-miRs
that target the PTEN gene in endometrioid endometrial carcinoma.
Anticancer Res. 35:1401–1410. 2015.PubMed/NCBI
|
|
28
|
Zhang Z, Yang C, Gao W, Chen T, Qian T, Hu
J and Tan Y: FOXA2 attenuates the epithelial to mesenchymal
transition by regulating the transcription of E-cadherin and ZEB2
in human breast cancer. Cancer Lett. 361:240–250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li H, Xu L, Zhao L, Ma Y, Zhu Z, Liu Y and
Qu X: Insulin-like growth factor-I induces epithelial to
mesenchymal transition via GSK-3beta and ZEB2 in the BGC-823
gastric cancer cell line. Oncol Lett. 9:143–148. 2015.
|
|
30
|
Chen Z, Tang ZY, He Y, Liu LF, Li DJ and
Chen X: miRNA-205 is a candidate tumor suppressor that targets ZEB2
in renal cell carcinoma. Oncol Res Treat. 37:658–664. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Usova EV, Kopantseva MR, Kostina MB,
Van'Kovich AN, Egorov VI and Kopantsev EP: Expression of the ZEB2
gene in pancreatic stromal cells in pancreatic ductal
adenocarcinoma, pancreatitis, and normal state. Dokl Biol Sci.
448:61–64. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chu PY, Hu FW, Yu CC, Tsai LL, Yu CH, Wu
BC, Chen YW, Huang PI and Lo WL: Epithelial-mesenchymal transition
transcription factor ZEB1/ZEB2 co-expression predicts poor
prognosis and maintains tumor-initiating properties in head and
neck cancer. Oral Oncol. 49:34–41. 2013. View Article : Google Scholar
|
|
33
|
Xia M, Hu M, Wang J, Xu Y, Chen X, Ma Y
and Su L: Identification of the role of Smad interacting protein 1
(SIP1) in glioma. J Neurooncol. 97:225–232. 2010. View Article : Google Scholar
|
|
34
|
Yang X, Wang J, Qu S, Zhang H, Ruan B, Gao
Y, Ma B, Wang X, Wu N, Li X, et al: MicroRNA-200a suppresses
metastatic potential of side population cells in human
hepatocellular carcinoma by decreasing ZEB2. Oncotarget.
6:7918–7929. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guo F, Cogdell D, Hu L, Yang D, Sood AK,
Xue F and Zhang W: miR-101 suppresses the epithelial-to-mesenchymal
transition by targeting ZEB1 and ZEB2 in ovarian carcinoma. Oncol
Rep. 31:2021–2028. 2014.PubMed/NCBI
|
|
36
|
You J, Li Y, Fang N, Liu B, Zu L, Chang R,
Li X and Zhou Q: MiR-132 suppresses the migration and invasion of
lung cancer cells via targeting the EMT regulator ZEB2. PLoS One.
9:e918272014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kurashige J, Kamohara H, Watanabe M,
Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y and
Baba H: MicroRNA-200b regulates cell proliferation, invasion, and
migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg
Oncol. 19(Suppl 3): S656–S664. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fang S, Zeng X, Zhu W, Tang R, Chao Y and
Guo L: Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by
miR-200b contributes to multi-drug resistance of small cell lung
cancer. Exp Mol Pathol. 96:438–444. 2014. View Article : Google Scholar : PubMed/NCBI
|
